Oncotarget

Vol 11, No 10

March 10, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 10 of Oncotarget features Figure 3, "Overall survival (OS) for high (red) versus low (black) risk groups in the (A) OSU, (B) TCGA, and (C) SNU resected cohorts," by Wolfe, et al.

Table of Contents

Research Perspectives

MicroRNA (miR) dysregulation during Helicobacter pylori-induced gastric inflammation and cancer development: critical importance of miR-155

MicroRNA (miR) dysregulation during Helicobacter pylori-induced gastric inflammation and cancer development: critical importance of miR-155

https://doi.org/10.18632/oncotarget.27520

Christian Prinz,  and David Weber
894-904
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Research Papers

DNA methylation of MMPs and TIMPs in atherothrombosis process in carotid plaques and blood tissues

DNA methylation of MMPs and TIMPs in atherothrombosis process in carotid plaques and blood tissues

https://doi.org/10.18632/oncotarget.27469

Cristina Gallego-Fabrega, Natalia Cullell, Carolina Soriano-Tárraga, Caty Carrera, Nuria P. Torres-Aguila, Elena Muiño, Jara Cárcel-Márquez, Manuel Castro de Moura, Alba Fernández-Sanlés, Manel Esteller, Roberto Elosua, Jordi Jiménez-Conde, Jaume Roquer, Joan Montaner, Jerzy Krupinski,  and Israel Fernandez-Cadenas
905-912
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

A microRNA-based signature predicts local-regional failure and overall survival after pancreatic cancer resection

A microRNA-based signature predicts local-regional failure and overall survival after pancreatic cancer resection

https://doi.org/10.18632/oncotarget.27496

Adam R. Wolfe, Patrick Wald, Amy Webb, Nikhil Sebastian, Steve Walston, Ryan Robb, Wei Chen, Marall Vedaie, Mary Dillhoff, Wendy L. Frankel, Wooil Kwon, Jin-Young Jang,  and Terence M. Williams
913-923
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Reviews

Prognostic and predictive factors in pancreatic cancer

Prognostic and predictive factors in pancreatic cancer

https://doi.org/10.18632/oncotarget.27518

Emanuela Dell’Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, Fabrizio Citarella, Marco Stellato, Francesco Pantano, Marco Russano, Maria Concetta Cursano, Andrea Napolitano, Tea Zeppola, Bruno Vincenzi, Giuseppe Tonini,  and Daniele Santini
924-941
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Corrections

Correction: Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*

Correction: Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*

https://doi.org/10.18632/oncotarget.27512

David M. Goldenberg, Thomas M. Cardillo, Serengulam V. Govindan, Edmund A. Rossi,  and Robert M. Sharkey
942-942
Correction  |  PDF  |  How to cite


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC